UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

Amendment No. 1

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2006

Commission File Number 000-52005

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

(Exact Name of Registrant As Specified In Its Charter)

DELAWARE	11-3504866
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

4940 Broadway Suite 201 San Antonio, TX 78209

(Address of principal executive office, including zip code)

(210) 824 - 4200

(Registrant's telephone number, including area code)

Issued pursuant to Section 12(b) of the Act:

None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.00001 per share

- 1 -

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   

¨ Yes  x No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   

¨ Yes  x No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:   

x Yes  ¨ No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.

o  Large accelerated filer o  Accelerated filer x Non-accelerated filer

Indicate by check mark whether the registrant is a shell company (defined in Rule 12b-2 of the Act).

o Yes   x No

The number of shares outstanding of Integrative Health Technologies, Inc.’s common stock on April 16, 2007 was 40,642,597.

- 2 -

EXPLANATORY NOTE

Integrative Health Technologies, Inc., or the Company, is filing this Amendment No. 1 on Form 10-K/A to its Annual Report on Form 10-K for the year ended December 31, 2006, or the 2006 Form 10-K, originally filed with the U.S. Securities and Exchange Commission on April 17, 2007, to amend Items 7 and 8, “Financial Statements,” and “Notes to Financial Statements,” respectively. The Financial Statements and Notes to Financial Statements have been audited and need to be included in the document.

The remainder of the information contained in the 2006 Form 10-KSB is not amended hereby and remains as set forth in the original filing.

PLEASE NOTE THAT THE INFORMATION CONTAINED IN THIS FORM 10-K/A, INCLUDING THE FINANCIAL STATEMENTS AND THE NOTES THERETO, DOES NOT REFLECT EVENTS OCCURRING AFTER THE DATE OF THE 2006 FORM 10-K OR MODIFY OR UPDATE THOSE DISCLOSURES AFFECTED BY SUBSEQUENT EVENTS.

SIGNATURE

In accordance with Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

Date: June 4, 2007	By: /s/ Dr. Gilbert R. Kaats
	Dr. Gilbert R. Kaats
	Chairman of the Board, President & Chief Executive Officer
	(Principal Executive and Financial Officer)

- 3 -

Integrative Health Technologies, Inc.

previously known as Senticore, Inc.

(A Development Stage Company)

AUDITED FINANCIAL STATEMENTS

December 31, 2006

TABLE OF CONTENTS

	Page
INDEPENDENT AUDITOR’S REPORT	5
BALANCE SHEET	6
STATEMENTS OF OPERATIONS	7
STATEMENTS OF CASH FLOWS	8
STATEMENTS OF STOCKHOLDERS’ EQUITY	9
NOTES TO THE FINANCIAL STATEMENTS	10 - 14

- 4 -

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and

Integrative Health Technologies, Inc.

I have audited the balance sheet of Integrative Health Technologies, Inc. as of December 31, 2006, and the related statements of operations, stockholders’ equity, and cash flows for the two years ended December 31, 2006 and 2005. These financial statements are the responsibility of the Company’s management. My responsibility is to express an opinion on these financial statements based on our audits.

I conducted my audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that I plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor was I engaged to perform, an audit of its internal control over financial reporting. My audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, I express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. I believe that my audits provide a reasonable basis for my opinion.

In my opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Integrative Health Technologies, Inc. as of December 31, 2006, and the results of its operations and its cash flows for the two years ended December 31, 2006 and 2005 in conformity with U.S. generally accepted accounting principles.

Traci J. Anderson, CPA

Huntersville, NC

May 30, 2007

- 5 -

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

previously known as Senticore, Inc.

(A Development Stage Company)

BALANCE SHEET

As of December 31, 2006

ASSETS
CURRENT ASSETS
Cash	$	29,673
Controlled Affiliated Issuers at value		7,980,249
Shareholder Loan Receivable		34,800
Accounts Receivable		350,266
Inventory		94,535
TOTAL CURRENT ASSETS		8,489,523
PROPERTY AND EQUIPMENT
Furniture, fixtures, and equipment, Net		18,500
Net Property and Equipment		18,500
OTHER ASSETS
Prepaid Trials		1,234,463
Net Other Assets		1,234,463
TOTAL ASSETS	$	9,742,486
LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES
Current Liabilities:
Accounts Payable	$	433,392
Shareholder Loan Payable		187,340
TOTAL LIABILITIES		620,732
STOCKHOLDERS' EQUITY
Preferred Stock ($.01 par value, 20,000,000 shares authorized:  20,000,000 shares issued and outstanding)		200,000
Common Stock ($.001 par value, 200,000,000 shares authorized: 144,735,787 shares issued and outstanding)		144,736
Additional Paid-in-Capital		11,278,056
Retained Deficit		(2,501,038	)
TOTAL STOCKHOLDERS' EQUITY		9,121,754
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	9,742,486

The accompanying notes are an integral part of these audited financial statements.

- 6 -

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

previously known as Senticore, Inc.

(A Development Stage Company)

STATEMENTS OF OPERATIONS

For the Years Ended December 31, 2006 and 2005

						Cumulative
						Total Since
						Inception
	2006		2005			January 5, 1999
SALES AND COST OF SALES
Sales	$	369,672	$	--		$	374,947
Cost of Sales		164,205		--			164,205
Gross Profit		205,467		--			210,742
OPERATING EXPENSES
Stock based compensation		--		--			2,586,341
Stock based interest		--		--			471,420
Selling, general and administrative		45,569		55,172			1,361,174
Total Operating Expenses		45,569		55,172			4,418,935
OTHER INCOME (LOSS)
Loss from disposal of fixed assets		--		--			(6,000	)
Loss on equity of LLC		--		--			(109,000	)
Gain on Sale of Investments		234,769		--			234,769
Total Other Income (Loss)		234,769		--			119,769
Net Income (Loss) From Operations before tax expense		394,667		(55,172	)		(4,088,424	)
Income Tax Expense		--		--			--
Net Income (Loss) From Operations		394,667		(55,172	)		(4,088,424	)
OTHER COMPREHENSIVE INCOME
Unrealized Gain (Loss) on Mark-to-market investment portfolio, net of  tax		536,512		--			531,512
Total Other Comprehensive Income		536,512		--			531,512
Comprehensive Income	$	931,179	$	(55,172	)	$	(3,556,912	)
Net Loss Per Common Share -- Basic & Fully Diluted	$	0.01		*
Weighted Average Common Shares Outstanding		144,735,787		181,145,154

*  Less than ($.01)

The accompanying notes are an integral part of these audited financial statements.

- 7 -

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

previously known as Senticore, Inc.

(A Development Stage Company)

STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2006 and 2005

							Cumulative
							Total Since
							Inception
	2006			2005			January 5, 1999
CASH FLOWS FROM OPERATING ACTIVITIES
Net Comprehensive Income (loss)	$	931,179		$	(55,172	)	$	(3,086,492	)
Adjustments to reconcile net increase (decrease):
Depreciation		--			--			24,318
Loss on Disposal of fixed assets		--			--			6,000
Loss on Equity in LLC		--			--			109,000
Stock based interest		--			23,750			495,170
Stock based compensation		--			--			2,600,341
Other stock based expenses		--			--			914,174
Proceeds from sale of investments		260,897			--			260,897
Realized Gain on sale of investments		(234,769	)		--			(234,769	)
Unrealized Gain on Mark to Market Investment Portfolio		(536,512	)		--			(531,512	)
(Increase) decrease in other assets		(34,800	)		7,867			(34,800	)
(Increase) in available for sale investments		--			(1,338,732	)		(1,338,732	)
Increase (decrease) in accounts payable and accrued payables		92,216			62,107			177,831
NET CASH PROVIDED (USED) IN OPERATING ACTIVITIES		478,211			(1,300,180	)		(638,574	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in Portfolio Company		(6,256	)		--			(6,256	)
Net Proceeds from sale of assets		4,500			--			4,500
Purchases of property, plant, and equipment		--			--			(5,789	)
Goodwill acquired (given back to seller due to unwinding)		--			908,759			--
Software received (given back due to unwinding) in purchase of Pokerbook		--			111,471			(18,529	)
NET CASH FROM INVESTING ACTIVITIES		(1,756	)		1,020,230			(26,074	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from borrowings under note payable		--			--			669,600
Repayments under note payable		(448,034	)		(369,600	)		(785,358	)
Excess of outstanding checks over bank balance		--			3,302			3,302
Proceeds from sale of land		--			--			135,000
Incurrence (repayment) of advances		--			189,000			--
Advances from stockholders		--			--			112,413
Capital contributions		--			--			19,846
Proceeds from issuance of common stock		--			458,500			539,518
NET CASH (USED) IN FINANCING ACTIVITIES		(448,034	)		281,202			694,321
NON-CASH FLOW INVESTING ACTIVITIES
Issuance of preferred stock (acquisition of companies)		7,469,025			--			7,469,025
Acquisitions of wholly owned subsidiaries, fixed assets, intangibles and liabilities		(7,469,025	)		--			(7,469,025	)
Issuance of portfolio holding in exchange for debt reduction		677,373			--			677,373
Debt reduction in exchange for portfolio holding		(677,373	)		--			(677,373	)
NET NON-CASH INVESTING ACTIVITIES		--			--			--
INCREASE (DECREASE) IN CASH		28,421			1,252			29,673
CASH AND CASH EQUIVALENTS
Beginning of Period		1,252			--			--
Ending of Period	$	29,673		$	1,252		$	29,673

The accompanying notes are an integral part of these audited financial statements.

- 8 -

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

previously known as Senticore, Inc.

(A Development Stage Company)

STATEMENTS OF STOCKHOLDERS' EQUITY

For the Years Ended December 31, 2006 and 2005

	Common		Common			Preferred		Preferred		Deferred Stock			Additional
	Shares		Stock			Shares		Shares		and Interest			Paid-in		Retained
	(000's)		$			(000's)		$		Compensation			Capital		Deficit
Balances, December 31, 2003		40,040	$	40,040			--	$	--	$	(314,950	)	$	492,256	$	(881,670	)
Shares canceled		(12,000		(12,000	)		--		--		--			--		--
Amortization of deferred compensation		--		--			--		--		291,200			--		--
Issuance of stock for services		21,841		21,841			--		--		--			2,107,417		--
Issuance of stock for interest, payable, acquisitions		74,150		74,150			--		--		--			971,603		--
Net Income (Loss) for the year		--		--			--		--		--			--		(2,835,517	)
Balances, December 31, 2004		124,031	$	124,031			--	$	--	$	(23,750	)	$	3,571,276	$	(3,717,187	)
Issuance of stock for cash		34,727		34,727			--		--		--			401,386		--
Issuance of stock for services		22,387		22,387			--		--		--			--		--
Amortization of deferred compensation		--		--			--		--		23,750			--		--
Net Income (Loss) for the year		--		--			--		--		--			--		(55,172	)
Balances, December 31, 2005		181,145	$	181,145			--	$	--	$	--		$	3,972,662	$	(3,772,359	)
Correction of an error		--		--			--		--		--			20		--
Shares canceled		(36,409		(36,409	)		--		--		--			36,349		--
Issuance of stock for acquisitions		--		--			20,000		200,000		--			7,269,025		--
Net Income (Loss) for the year		--		--			--		--		--			--		1,271,321
Balances, December 31, 2006		144,736	$	144,736			20,000	$	200,000	$	--		$	11,278,056	$	(2,501,038	)

The accompanying notes are an integral part of these audited financial statements

- 9 -

INTEGRATIVE HEALTH TECHNOLOGIES, INC.

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2006

NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business Activity

Integrative Health Technologies, Inc. formerly known as Senticore, Inc. (The Company) was incorporated under the laws of the state of Delaware on January 5, 1999. On February 11, 2005 The Company elected under the Investment Company Act of 1940 (the “ICA”) to become a Business Development Company (“BDC”). This means that, from that date and continuing through the year ended December 31, 2006, the Company operated as a publicly-traded, closed-end investment company which, because of its BDC election, could raise money in the public sector and invest in the private sector. However, as disclosed below in the Note “Subsequent Events”, on May 6, 2007 the Company withdrew its BDC election.

Business Description

During the year ended December 31, 2006, the Company was a BDC providing capital, equipment, scientific advice and extensive hands-on managerial assistance to portfolio companies in the healthcare and nutritional industries.  The company also held some investments in three public companies and one private company that are not in the healthcare and nutritional industries. IHTI’s three major healthcare and nutritional portfolio companies are all wholly-owned subsidiaries of IHTI: (1) Health and Medical Research Inc. is a clinical research organization that has conducted clinical trials and research for over 20 years capitalizing on the growing importance of scientific support for the marketing of healthcare and nutritional products and technologies; (2) HealthTech Development, LLC provides consulting to healthcare and nutritional companies and product research and development including feasibility and marketing studies, and; (3) HealthTech Products, LLC markets clinically-tested healthcare and nutritional products.

Basis of Presentation

The financial statements included herein were prepared under the accrual basis of accounting.

Cash and Cash Equivalents

For purposes of the Statement of Cash Flows, the Company considers liquid investments with an original maturity of three months or less to be cash equivalents.

Management’s Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The financial statements above reflect all of the costs of doing business.

Revenue Recognition

The Company’s policy is to recognize income when it is earned.

- 10 -

Comprehensive Income (Loss)

The Company adopted Financial Accounting Standards Board Statement of Financial Accounting Standards (SFAS) No. 130, “Reporting Comprehensive Income”, which establishes standards for the reporting and display of comprehensive income and its components in the financial statements.

Development Stage

The Company is considered to be in the development stage as defined by Statement of Financial Accounting Standards (SFAS) No. 7 and, accordingly, most of its accounting policies and procedures have not yet been established.

Net Income per Common Share

Statement of Financial Accounting Standard (SFAS) No. 128 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations.  Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per share would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Accordingly, this presentation has been adopted for the period presented. There were no adjustments required to net income for the period presented in the computation of diluted earnings per share.

Deferred Taxes

Income taxes are provided in accordance with Statement of Financial Accounting Standards No. 109 (SFAS No. 109), “Accounting for Income Taxes.” A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss-carry forwards.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that, some portion or all of the deferred tax asset will not be realized. Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment.

Impairment of Long-Lived Assets

The Company evaluates the recoverability of its fixed assets and other assets in accordance with Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (“SFAS 144’). SFAS 144 requires recognition of impairment of long-lived assets in the event the net book value of such assets exceeds its expected cash flows, it is considered to be impaired and is written down to fair value, which is determined based on either discounted future cash flows or appraised values. The Company adopted the statement on inception. No impairments of these types of assets were recognized during the period ended December 31, 2006.

Fair Value of Financial Instruments

The carrying amounts reported in the balance sheet for cash, accounts receivable and payable approximate fair value based on the short-term maturity of these instruments.

Accounts Receivable

Accounts deemed uncollectible are written off in the year they become uncollectible. No receivables were deemed uncollectible as of December 31, 2006.

Stock-Based Compensation

The Company accounts for stock-based compensation using the fair value method of Financial Accounting Standard No. 123. Common shares issued for services rendered by a third party (both employees and non-employees) are recorded at the fair value of the shares issued or services rendered, whichever is more readily determinable.

- 11 -

Recent Accounting Pronouncements

In March 2006, the FASB issued SFAS No. 156. This Statement amends FASB Statement No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities, with respect to the accounting for separately recognized servicing assets and servicing liabilities. This Statement is effective as of the beginning of its first fiscal year that begins after September 15, 2006. An entity should apply the requirements for recognition and initial measurement of servicing assets and servicing liabilities prospectively to all transactions after the effective date of this Statement.

In September 2006, the FASB issued SFAS No. 157 and No. 158. Statement No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements, the Board having previously concluded in those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly, this Statement does not require any new fair value measurements. However, for some entities, the application of this Statement will change current practice.

Statement No. 158 is an amendment of FASB Statements No. 87, 88, 106, and 132(R). It improves financial reporting by requiring an employer to recognize the over funded or under-funded status of a defined benefit postretirement plan (other than a multiemployer plan) as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year in which the changes occur through comprehensive income of a business entity or changes in unrestricted net assets of a not-for-profit organization. This Statement also improves financial reporting by requiring an employer to measure the funded status of a plan as of the date of its year-end statement of financial position, with limited exceptions.

The Company does not expect application of SFAS No. 156, 157 and 158 to have a material effect on its financial statements.

NOTE B—SUPPLEMENTAL CASH FLOW INFORMATION

Supplemental disclosures of cash flow information for the period ended December 31, 2006 is summarized as follows:

Cash paid for interest and income taxes:

	December 31, 2006
Income Taxes	$	--
Interest	$	--

NOTE C—SEGMENT REPORTING

In June 1997, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 131, “Disclosures about Segments of an Enterprise and Related Information.” This statement requires companies to report information about operating segments in interim and annual financial statements. It also requires segment disclosures about products and services, geographic areas and major customers. The Company determined that it did not have any separately reportable operating segments as of December 31, 2006.

NOTE D—COMMITMENTS

As of December 31, 2006, the Company has a lease commitment to rent office space. The rental expense for 2006 is $4,600. The lease expired on December 31, 2006.

- 12 -

NOTE E—INCOME TAXES

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for federal and state income tax purposes.

The Company’s total deferred tax asset, calculated using federal and state effective tax rates, as of December 31, 2006 is as follows:

Total deferred tax assets	$	124,000
Valuation allowance		(124,000	)
Net deferred tax asset	$	--

The reconciliation of income taxes computed at the federal statutory income tax rate to total income taxes for the period ended December 31, 2006:

Income tax computed at the federal statutory rate	34.0	%
State income taxes, net of federal tax benefit	4.8	%
Valuation allowance	(38.8	%)
Total deferred tax asset	0	%

Because of the Company’s lack of earnings history, the deferred tax asset has been fully offset by a valuation allowance. The valuation allowance increased (decreased) by approximately $(153,000) and $21,000 for the years ended December 31, 2006 and 2005 respectively.

As of December 31, 2006, the Company had federal and state net operating loss carryforwards in the amount of approximately $319,000 which expire at various times through the year 2026.

NOTE F—NOTES PAYABLE AND SHAREHOLDER RECEIVABLE/RELATED PARTY

As of December 31, 2006, the Company had no outstanding Notes Payable, but it did have an outstanding, non-interest bearing, demand Notes Payable with its major shareholders. The total amount of the Notes Payable to the shareholders was $187,340 as of December 31, 2006.

As of December 31, 2006, the Company had an outstanding Shareholder Loan Receivable with one of its major shareholders is the amount of $34,800.

NOTE G—RELATED PARTY TRANSACTIONS

On August 15, 2006 The Company entered into an agreement with an investment company to purchase sufficient shares of the Company’s stock in Taj Systems, Inc., a pink-sheet company trading under the symbol TJSS, to eliminate all of the Company’s $671,927 outstanding liabilities that it had at closing. The TJSS shares in question are restricted shares, but could be converted into common stock as of August 31, 2006. However, the agreement is not contingent upon this convertibility. The investor provided an initial payment of $114,969 and agreed to pay for this stock in five payments over the next five months (as of this filing date, all five payments have been received.) Upon receipt of all payments, the Company has agreed to transfer these restricted shares to the investor. The Board of Directors has approved the sale with the restriction that all proceeds must be used for the reduction of outstanding debts, and not for operating capital or executive or consultant compensation.

NOTE H—SUBSEQUENT EVENTS

On May 6, 2007, the Company filed a form N-54C with the SEC revoking its earlier election to become a BDC.

- 13 -

NOTE I—CONTROLLED AFFILIATED ISSUERS

The following is a table detailing the Company’s Portfolio of Holdings and Investments of its Controlled Affiliated Issuers:

Publicly-Traded Companies FMV at 12/31/2006	Acquisition Date	Shares		Price per share		Fair Market Value		Cost		Unrealized Gain(Loss)
Taj Systems (TJSS)			1,281,886	$	0.115	$	147,417	$	236,233	$	(88,816	)
AdZone Research (ADZR)			882,353	$	0.003	$	2,647	$	--	$	2,647
Beere Financial (BRFG)			2,308	$	0.100	$	231	$	10,000	$	(9,769	)
Integrated Health Tech (IHT)			6,874	$	0.560	$	3,849	$	6,256	$	(2,407	)
		subtotal				$	154,144	$	252,489
Non Controlled Companies (Non-Publicly traded)
8% Equity Position in AlgaeCal International	October 2006					$	320,000	$	320,000	$	--
The Justice Fund, a privately held corporation			11,000,000	$	0.100	$	110,000	$	--	$	110,000
Controlled Companies (Non-Publicly traded)
100% Health and Medical Research, Inc.	August 2006					$	7,361,998	$	6,531,106	$	830,892
100% HealthTech Products, LLC	August 2006					$	--	$	--	$	--
100% HealthTech Development, LLC	August 2006					$	34,107	$	--	$	34,107
		subtotal				$	7,826,105	$	6,851,106
				Totals		$	7,980,249	$	7,103,595
Unrealized Gain (Loss) at 12/31/2006										$	876,653
Portfolio Holdings @ at 12/31/2006						$	7,980,249

- 14 -